X0304 4 2012-02-01 0 0001379246 BODY CENTRAL CORP BODY 0001503341 Angelo Beth C/O BODY CENTRAL CORP. 6225 POWERS AVENUE JACKSONVILLE FL 32217 1 1 0 0 EVP & Chief Merchandising Ofcr Common Stock 2012-02-01 4 S 0 11538 26.3022 D 128005 D Common Stock 2012-02-02 4 M 0 6171 3.94 A 134176 D Common Stock 2012-02-02 4 S 0 346 24.9756 D 133830 D Common Stock 2012-02-02 4 S 0 4250 25.7053 D 129580 D Common Stock 2012-02-02 4 S 0 5037 26.2164 D 124543 D Employee Stock Option (right to buy) 3.94 2012-02-02 4 M 0 6171 0 D 2020-10-12 Common Stock 6171 135578 D The reported sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.02 to $26.87, inclusive. The reporting person undertakes to provide to Body Central Corp., any security holder of Body Central Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Includes 8,435 restricted shares granted pursuant to the Company's Equity Incentive Plan. Shares vest 25% per year beginning on September 16, 2012. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.97 to $24.99, inclusive. The reporting person undertakes to provide to Body Central Corp., any security holder of Body Central Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.997, inclusive. The reporting person undertakes to provide to Body Central Corp., any security holder of Body Central Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.465, inclusive. The reporting person undertakes to provide to Body Central Corp., any security holder of Body Central Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Twenty-five percent of the shares underlying the option vested on October 12, 2010. The balance of the shares vest in 12 equal quarterly installments beginning January 12, 2011 and ending October 12, 2013. /s/ Michael B. Kirwan, Attorney-in-Fact for Beth Angelo 2012-02-03